BIIB

First Pill for Postpartum Depression Is Approved by FDA

The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a…

2 years ago

Biogen to Buy Reata in $7.3 Billion Deal

The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link

2 years ago

Biogen to Cut Roughly 11% of Workforce

The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link

2 years ago

FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients

Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link

2 years ago